Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Clinical trial NCT02119286 · COMPLETED
Trial details
- NCT number
- NCT02119286
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.